Breaking News Instant updates and real-time market news.

Rumor: Depomed moves up on speculation the company canceled a conference

29

Nov

DEPODepomed

$23.83

-0.26 (-1.08%)

07/07/16

07/07/16DOWNGRADE

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AT&T (T) downgraded to Neutral from Buy at Citi with analyst Michael Rollins citing valuation. 2. First Solar (FSLR) downgraded to Hold from Buy at Deutsche Bank with analyst Vishal Shah saying he sees downside risk to the company's 2017 earnings. 3. Depomed (DEPO) downgraded to Neutral from Buy at UBS with analyst Ami Fadia saying the company's sales guidance is at risk. 4. Red Hat (RHT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Keith Weiss saying mid-teens billings growth with flat to down margins limits upside to free-cash-flow projections and said valuation is fair to his $80 price target. 5. Bank of America (BAC) and Wells Fargo (WFC) downgraded to Market Perform from Outperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Northland raised Depomed's price target to $30 from $25 to reflect the reported $32 per share takeover value discounted by 6%. The firm's analyst said a company sale mandate could take place following issuance of a decision in Nucynta family patent litigation with a Federal District Court judge set to rule by end of September.

10/04/16

MZHO

10/04/16DOWNGRADEMZHONeutral

Depomed downgraded to Neutral from Buy at Mizuho

Mizuho analyst Irina Koffler downgraded Depomed with a Buy due to valuation with a $27 price target on shares.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.